1. Home
  2. MLYS vs PLOW Comparison

MLYS vs PLOW Comparison

Compare MLYS & PLOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLYS
  • PLOW
  • Stock Information
  • Founded
  • MLYS 2019
  • PLOW 1948
  • Country
  • MLYS United States
  • PLOW United States
  • Employees
  • MLYS N/A
  • PLOW N/A
  • Industry
  • MLYS Biotechnology: Pharmaceutical Preparations
  • PLOW Construction/Ag Equipment/Trucks
  • Sector
  • MLYS Health Care
  • PLOW Industrials
  • Exchange
  • MLYS Nasdaq
  • PLOW Nasdaq
  • Market Cap
  • MLYS 590.3M
  • PLOW 634.9M
  • IPO Year
  • MLYS 2023
  • PLOW 2010
  • Fundamental
  • Price
  • MLYS $13.88
  • PLOW $27.02
  • Analyst Decision
  • MLYS Strong Buy
  • PLOW Buy
  • Analyst Count
  • MLYS 2
  • PLOW 2
  • Target Price
  • MLYS $30.00
  • PLOW $28.00
  • AVG Volume (30 Days)
  • MLYS 122.0K
  • PLOW 135.7K
  • Earning Date
  • MLYS 11-05-2024
  • PLOW 10-28-2024
  • Dividend Yield
  • MLYS N/A
  • PLOW 4.36%
  • EPS Growth
  • MLYS N/A
  • PLOW N/A
  • EPS
  • MLYS N/A
  • PLOW 1.19
  • Revenue
  • MLYS N/A
  • PLOW $573,923,000.00
  • Revenue This Year
  • MLYS N/A
  • PLOW $8.69
  • Revenue Next Year
  • MLYS N/A
  • PLOW $9.01
  • P/E Ratio
  • MLYS N/A
  • PLOW $22.75
  • Revenue Growth
  • MLYS N/A
  • PLOW N/A
  • 52 Week Low
  • MLYS $5.85
  • PLOW $21.31
  • 52 Week High
  • MLYS $16.91
  • PLOW $31.52
  • Technical
  • Relative Strength Index (RSI)
  • MLYS 70.82
  • PLOW 44.64
  • Support Level
  • MLYS $11.73
  • PLOW $26.81
  • Resistance Level
  • MLYS $12.27
  • PLOW $27.78
  • Average True Range (ATR)
  • MLYS 0.61
  • PLOW 0.62
  • MACD
  • MLYS 0.19
  • PLOW -0.12
  • Stochastic Oscillator
  • MLYS 98.50
  • PLOW 9.32

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking three or more antihypertensive medications typically including a diuretic.

About PLOW Douglas Dynamics Inc.

Douglas Dynamics Inc is a manufacturer and upfitter of commercial vehicle attachments and equipment. The Company's portfolio includes snow and ice management attachments sold under the BLIZZARD, FISHER, HENDERSON, SNOWEX, and WESTERN brands, turf care equipment under the TURFEX brand, and industrial maintenance equipment under the SWEEPEX brand. The Company's portfolio also includes the upfit of attachments and storage solutions under the HENDERSON brand, and the DEJANA brand and its related sub-brands. The Company also leases fifteen manufacturing upfit and service facilities located in Iowa, Maryland, Missouri, New Jersey, New York, Ohio, Pennsylvania, and Rhode Island. The Company conducts business in two segments: Work Truck Attachments and Work Truck Solutions.

Share on Social Networks: